Lumosa Therapeutics Co., Ltd. announced the appointment of Hsin-Jung Lin as Member of the Audit Committee. Effective date May 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
180 TWD | -4.00% | -1.10% | +163.54% |
05-14 | Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-14 | Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.54% | 955M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- 6535 Stock
- News Lumosa Therapeutics Co., Ltd.
- Lumosa Therapeutics Co., Ltd. Appoints Hsin-Jung Lin as Member of the Audit Committee